Contract Pharma is a leading brand in the global biotechnology and pharmaceutical services outsourcing market. With a market value of $60 billion in 2020 and expected to surpass $100 billion by the end of the decade, Contract Pharma is dedicated to connecting contract service providers with pharma and biopharma sponsors. As pricing pressures rise and internal capabilities at sponsor organizations face challenges, Contract Pharma offers a vital platform for navigating the complex drug development landscape.

From contract research organizations (CROs) to contract manufacturing organizations (CMOs) and contract development and manufacturing organizations (CDMOs), Contract Pharma provides a range of products and services through its digital platform and print publication. Whether through print or digital channels, Contract Pharma ensures maximum brand exposure and facilitates essential connections with key decision-makers in the industry. Stay updated with the latest breaking news and trends in biopharma and pharmaceutical services with Contract Pharma